- European indices finished today's session mostly lower, with Dax falling 0.12%, while pharma giant Bayer stock jumped more than 4% on news that its new blood clot drug could make over €5 billion in annual sales.
-
Electricity prices in Germany bottomed below €100/MWh in January, easing further from their December peak of €450/MWh, thanks to lower prices of natural gas, a rise in renewable power production, and lower demand.
-
ECB board member Schnabel said financing conditions would need to become restrictive to resolve the ongoing inflation problem, adding that interest rates would still be raised significantly at a steady pace to ensure a timely return of inflation to the 2% target.
-
On the other hand, ECB's Centeno believes that the end of interest rate rise process is approaching
-
Major Wall Street indices rose slightly on Tuesday as a highly anticipated speech from Powell in Sweden did not cause any major moves on the markets. Powell noted that stabilizing prices requires making tough decisions that can be unpopular politically.
-
Dow Jones trading 0.30% higher, while the S&P 500 and Nasdaq fell 0.40% and 0.60% respectively and now traders brace themselves for US inflation data on Thursday and start of earnings season on Friday, which may provide hints into how the Fed will move interest rates going forward.
-
Fed's Bowman said that despite recent decreases in some inflation measures, there is still a lot of work to be done. She will be looking for convincing evidence that inflation has peaked, as well as more consistent indicators that inflation is on the decline.
-
Oil erased early gains and is trading over 1.205 higher on prospects for a rebound in economic activity in China. Also EIA raised the forecast for 2023 world oil demand by 50,000 bpd to 1.05 million bpd, while US crude production is expected to increase to 550k bpd to 12.41 million bpd in 2023 vs prior estimates of +470k bpd.
-
Mixed mood prevails on the precious metals market amid a stronger dollar. Gold rose slightly and managed to break above $1875 level, while silver pulled back to $23.50 mark.
-
Price movements in the Forex market were rather moderate today and the US dollar managed to halt the recent downward movement. Greenback strengthened more than 0.2% against the franc and pound, and about 0.3% against JPY, CAD and AUD.
-
The vast majority of cryptocurrencies moved higher on Tuesday. The scale of increases is smaller compared to yesterday’s session, nevertheless positive sentiment persists. Bitcoin adds another 1% and is slowly heading towards a key resistance zone between $17,500 and $18,000.
SILVER rally has lost some steam recently, but the bulls still seem to be in control. Looking at the H4 interval, the price is currently struggling with the EMA100 average, which acted as significant support in the past. Should break lower occur, downward move may deepen towards support at $23.3 where the lower limit of the 1:1 pattern can be found. Source: xStation5
Daily Summary: End of an Extremely Intense Week (19.06.2026)
Three markets to watch next week: EURUSD, OIL, NASDAQ (19.06.2026)
US Closed: Postponed negotiations weigh on futures
🚩 Gold loses 1.5% as Goldman Sachs cuts its 2026 bullion price target
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.